With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia||Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD||Young Investigator Grants||2019||California|
|The Role of Pyruvate Dehydrogenase in Leukemia||University of Texas Southwestern Medical Center at Dallas / Michalis Agathocleous, PhD||'A' Award Grants||2018||Texas|
|The Role of PTPRD as a Tumor Suppressor in Neuroblastoma Pathogenesis||Mayo Clinic / Shizhen Zhu, MD, PhD||Young Investigator Grants||2013||Minnesota|
|The Role of Prmt1 in Osteosarcoma Initiation and Metastasis||Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD||Young Investigator Grants||2013||Massachusetts|
|The role of primary cilia in rhabdomyosarcoma||New York University School of Medicine / Brian Dynlacht, PhD||Innovation Grants||2011||New York|
|The role of PDE4B in Racial Disparities in Outcome of Childhood Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Jun Yang||Young Investigator Grants||2010||Tennessee|
|The Role of PASG in Mediating Epigenetic Change and Outcome in AML.||The Johns Hopkins University School of Medicine / Jason Farrar, MD||Young Investigator Grants||2007||Maryland|
|The Role of PARP3 in the Formation of Chromosomal Translocations||Dana-Farber Cancer Institute / Tovah Day, PhD||Young Investigator Grants||2015||Massachusetts|
|The role of overexpressed microRNA’s in the pediatric cancer rhabdomyosarcoma||University of Pennsylvania / Frederic Barr, MD, PhD||Innovation Grants||2007||Pennsylvania|
|The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia||Children's Hospital Los Angeles / Markus Muschen||Innovation Grants||2008||California|